VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,940,000 | +76.0% | 121,483 | +59.9% | 1.19% | +85.8% |
| Q3 2021 | $2,239,000 | -27.6% | 75,983 | -16.5% | 0.64% | -19.8% |
| Q2 2021 | $3,092,000 | -11.9% | 90,983 | -15.7% | 0.80% | -13.3% |
| Q1 2021 | $3,509,000 | -12.2% | 107,983 | -2.7% | 0.92% | -8.7% |
| Q4 2020 | $3,998,000 | +7.5% | 110,983 | +16.8% | 1.01% | -4.4% |
| Q3 2020 | $3,720,000 | -3.4% | 94,983 | -9.5% | 1.06% | -16.9% |
| Q2 2020 | $3,851,000 | +66.5% | 104,983 | +4.6% | 1.27% | +54.3% |
| Q1 2020 | $2,313,000 | +61.0% | 100,365 | +104.6% | 0.82% | +114.9% |
| Q4 2019 | $1,437,000 | +9.8% | 49,065 | +141.8% | 0.38% | +19.3% |
| Q3 2019 | $1,309,000 | +13.8% | 20,290 | -54.9% | 0.32% | +3.2% |
| Q2 2019 | $1,150,000 | -12.2% | 45,000 | -22.8% | 0.31% | -11.4% |
| Q1 2019 | $1,310,000 | +38.0% | 58,300 | +29.6% | 0.35% | +16.6% |
| Q4 2018 | $949,000 | – | 45,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |